Jason N. Butler
Stock Analyst at Citizens
(3.83)
# 561
Out of 5,090 analysts
11
Total ratings
72.73%
Success rate
6.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $4.62 | +311.26% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $29.50 | +171.19% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $14.50 | +51.72% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $10.42 | +63.15% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $114.51 | -0.45% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $10.56 | +108.33% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $65.67 | +18.78% | 1 | Sep 2, 2025 | |
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $3.60 | +122.22% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $8.71 | +106.66% | 1 | Aug 13, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $30 → $35 | $27.44 | +27.55% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $63.33 | +23.16% | 1 | Aug 6, 2025 |
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $4.62
Upside: +311.26%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $29.50
Upside: +171.19%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $14.50
Upside: +51.72%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $10.42
Upside: +63.15%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $114.51
Upside: -0.45%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $10.56
Upside: +108.33%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $65.67
Upside: +18.78%
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $3.60
Upside: +122.22%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $8.71
Upside: +106.66%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Market Outperform
Price Target: $30 → $35
Current: $27.44
Upside: +27.55%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $63.33
Upside: +23.16%